Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Frequency-dependent modulation of dopamine release by nicotine

Nature Neuroscience volume 7, pages 581–582 (2004)Cite this article

Abstract

Although nicotine activation of dopamine release is implicated in addiction, it also desensitizes nicotinic acetylcholine receptors (nAChRs), leading to a prolonged depression of evoked dopamine release. Here we show that nicotine's effects depend on the firing pattern of dopamine neurons, so that while desensitization of nAChRs indeed curbs dopamine released by stimuli emulating tonic firing, it allows a rapid rise in dopamine from stimuli emulating phasic firing patterns associated with incentive/salience paradigms. Nicotine may thus enhance the contrast of dopamine signals associated with behavioral cues.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Modulation of evoked dopamine (DA) release by nAChRs depends on firing pattern.
Figure 2: Effect of nicotine on short-term facilitation.

Similar content being viewed by others

References

  1. Hyland, B.I., Reynolds, J.N., Hay, J., Perk, C.G. & Miller, R. Neuroscience 114, 475–492 (2002).

    Article  CAS  Google Scholar 

  2. Schultz, W. J. Neurophysiol. 56, 1439–1461 (1986).

    Article  CAS  Google Scholar 

  3. Phillips, P.E., Stuber, G.D., Heien, M.L., Wightman, R.M. & Carelli, R.M. Nature 422, 614–618 (2003).

    Article  CAS  Google Scholar 

  4. Jones, I.W., Bolam, J.P. & Wonnacott, S. J. Comp. Neurol. 439, 235–247 (2001).

    Article  CAS  Google Scholar 

  5. Grenhoff, J., Aston-Jones, G. & Svensson, T.H. Acta Physiol. Scand. 128, 351–358 (1986).

    Article  CAS  Google Scholar 

  6. Mansvelder, H.D., De Rover, M., McGehee, D.S. & Brussaard, A.B. Eur. J. Pharmacol. 480, 117–123 (2003).

    Article  CAS  Google Scholar 

  7. Di Chiara, G. Eur. J. Pharmacol. 393, 295–314 (2000).

    Article  CAS  Google Scholar 

  8. Zhou, F.M., Liang, Y. & Dani, J.A. Nat. Neurosci. 4, 1224–1229 (2001).

    Article  CAS  Google Scholar 

  9. Kudernatsch, M. & Sutor, B. Neurosci. Lett. 181, 107–112 (1994).

    Article  CAS  Google Scholar 

  10. Kulak, J.M., McIntosh, J.M., Yoshikami, D. & Olivera, B.M. J. Neurochem. 77, 1581–1589 (2001).

    Article  CAS  Google Scholar 

  11. Cragg, S.J. J. Neurosci. 23, 4378–4385 (2003).

    Article  CAS  Google Scholar 

  12. Schmitz, Y., Benoit-Marand, M., Gonon, F. & Sulzer, D. J. Neurochem. 87, 273–289 (2003).

    Article  CAS  Google Scholar 

  13. Schilstrom, B., Svensson, H.M., Svensson, T.H. & Nomikos, G.G. Neuroscience 85, 1005–1009 (1998).

    Article  CAS  Google Scholar 

  14. Levin, E.D. & Rezvani, A.H. Curr. Drug Target CNS Neurol. Disord. 1, 423–431 (2002).

    Article  CAS  Google Scholar 

  15. Zhang, H. & Sulzer, D. J. Neurosci. 23, 10585–10592 (2003).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Y. Schmitz and K. Larsen for critical reading of this manuscript, and E. Mosharov for software design. This work was supported by the National Institute on Drug Abuse, the Lowenstein Foundation and the Parkinson's Disease Foundation.

Author information

Authors and Affiliations

  1. Department of Neurology, Columbia University, 650 W 168th Street, New York, 10032, New York, USA

    Hui Zhang & David Sulzer

  2. Department of Psychiatry, Columbia University and Department of Neuroscience, New York State Psychiatric Institute, New York, 10032, New York, USA

    David Sulzer

Authors
  1. Hui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Sulzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Sulzer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Frequency-dependent modulation of evoked dopamine release by nicotine with distal stimulation at the MFB. (a, b) Effect of number of stimulation pulses and frequency on the modulation of evoked dopamine release by nicotine (Nic, 300 nM). The effects of nicotine were nearly identical to that of local stimulation in the nAcc Shell (compare to Fig. 1 in the text). Experiments were performed in six horizontal slices from three pTH-GFP mice. The recording electrode was placed in the nAcc shell and the stimulating electrode was placed at the MFB outside of the striatum, at least 500 μm away from the recording site (mean ± s.e.m., n = 6; *P < 0.05 compared with respective control values by Student's test). Upper panels: Evoked dopamine release normalized to that elicited by 1p stimulation under control condition. Lower panels: Relative evoked DA release after nicotine and mecamylamine at different stimulation pulses. (PDF 23 kb)

Supplementary Methods (PDF 14 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, H., Sulzer, D. Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7, 581–582 (2004). https://doi.org/10.1038/nn1243

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn1243

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing